Welcome to the IPC Psoriasis Masterclass for North America, an exclusive educational opportunity for early-to-mid-career dermatologists and other healthcare professionals actively managing and treating psoriasis. With a focus on fostering a small group environment, this FREE program offers an intimate and personalized learning experience, ensuring each participant receives the utmost attention and support.
Over the past five years, we have successfully hosted the IPC Psoriasis Masterclass worldwide, including the Middle East and Africa, Latin America, Eastern Europe, and Asia, engaging nearly 1,000 participants from an impressive 62 countries. We are bringing this unique program to North America for the first time.
This Masterclass is led by an esteemed faculty of international experts boasting extensive experience in psoriasis care. Our aim is to equip attendees with cutting-edge skills and knowledge to elevate their careers and become leaders in the field of psoriasis.
Generously sponsored by our corporate partners, IPC will cover the cost of your 1-night stay at the Luxor Hotel and Casino, and will provide a reception on Saturday, and breakfast on Sunday during the program.
Schedule:
Saturday, November 4
13:00– Registration
14:00 – Program Begins
18:00 – Program Ends
18:00 – Reception
Sunday, November 5
7:00 – Breakfast
8:00 – Program Begins
12:00 – Program Ends
The Masterclass is open to only 60 exceptional participants, carefully selected from those eager to elevate their expertise in managing and treating psoriasis. If you are a Dermatologist, Nurse Practitioner, Physician Assistant, or Dermatology Resident from North America with a strong foundation in dermatology, this program is tailor-made for you.
The application period for the IPC Psoriasis Masterclass for North America is now closed.
Brief Summary of the Course
The IPC Psoriasis Masterclass for North America is an intensive, eight-hour educational program designed for early-to-mid-career dermatologists and healthcare professionals interested in specializing in psoriasis care. With a focus on fostering a small group environment, the Masterclass provides a personalized learning experience, empowering participants to excel in their careers and become leaders in the field of psoriasis.
The agenda has been carefully designed to ensure participants gain the skills and knowledge required to manage patients effectively. Participants will engage in dynamic discussions, interactive Q&A sessions, and invaluable networking opportunities with distinguished experts in the field.
Learning Outcomes
Topics Covered
Prerequisites
The IPC Psoriasis Masterclass is for early-mid career dermatologists and other health professionals who are making treatment decisions and managing patients with psoriasis and have a strong foundation in dermatology.
REGISTRATION – 13:00
WELCOME + INTRODUCTION
Immunopathogenesis of Psoriasis and How it Relates to Drug Development
Andrew Blauvelt, MD, MBA
Portland, Oregon, United States
Phenotypes and Assessment of Psoriasis
Kristina Callis Duffin, MD
Salt Lake City, Utah, United States
Psoriasis-Related Comorbidities and their Management
Richard Langley, FRCPC, FACP
Halifax, Canada
Q & A
BREAK
Optimizing the Use of Topicals and Phototherapy
Colby Evans, MD
Austin, Texas, United States
Optimizing the Use of Oral Therapies – Old and New
Richard Langley, FRCPC, FACP
Halifax, Canada
Optimizing the Use of Biologics
Benjamin Ehst, MD, PhD
Portland, Oregon, United States
Q & A
RECEPTION & NETWORKING
BREAKFAST – 7:00 – 8:00
WELCOME
Psoriatic Arthritis for Dermatologists
Kristina Callis Duffin, MD
Salt Lake City, Utah, United States
Management of Psoriasis in Special Populations
Colby Evans, MD
Austin, Texas, United States
Management of Psoriasis Involving High Impact Areas
Benjamin Ehst, MD, PhD
Portland, Oregon, United States
Classification and Management of Pustular Psoriasis
Jason Hawkes, MD, MS
Sacramento, California, United States
Q & A
BREAK
Psoriasis Case Session
All
Q & A
CLOSING COMMENTS AND WRAP-UP
Lodging and Meeting Location:
The Luxor Hotel and Casino
3900 S. Las Vegas Blvd
Las Vegas, NV 89119
Check-in: 15:00 | Check-out: 11:00
Hotel FAQs
Thanks to the generous support of our sponsors, IPC will pay for a 1-night stay at Luxor Hotel and Casino in Las Vegas for each participant.
Transportation
IPC is offering a $500 travel stipend to cover participant’s air and ground transportation to the event. Reimbursement details will be sent following the event and will require full participation.
We recommend booking your flights well in advance to secure the best rates and ensure that your travel plans allow attendance for the entire program.
The nearest airport to the venue, Luxor Hotel and Casino, is the Harry Reid International Airport (LAS).
Ground
The estimated travel time from Harry Reid International Airport (LAS) to Luxor Hotel and Casino is 10 to 15 minutes by car, depending on traffic conditions.
Transportation Options and Estimated Costs:
Please note that the estimated costs above may vary based on travel demand, time of day, and any special events in Las Vegas. Participants are encouraged to plan their ground transportation according to their preferences and schedule.
Meals
Dinner will be provided on Saturday, November 4, and breakfast and lunch will be provided on Sunday, November
We would like to offer everyone a discount on the Medscape Live Dermatology Seminar from November 2 – 4 in Las Vegas. Please use the discount code IPC30 for 30% off your registration.
A new IPC paper in JAAD presents five priorities for improving metabolic screening, advancing GLP-1 research in the context of psoriasis, and defining the dermatologist’s role in managing cardiometabolic risk in psoriasis patients.
IPC Jr. Councilor Mio Nakamura speaks with Dr. John Koo about how personality traits, including borderline personality disorder, shape clinical interactions and shares practical strategies for dermatologists to build stronger patient relationships.
Recordings from the IPC Fellows Research Class #1: Global and Collaborative Research in Psoriasis are now available. Program Chairs Peter van de Kerkhof, MD, PhD, and María Julia Cura, MD, led a faculty of international experts through sessions on unresolved questions in the era of effective psoriasis therapies, building global research collaborations, and connecting psoriasis research across disciplines. Watch to hear from Wolf Henning Boehncke, MD, MA, Christopher Griffiths, OBE, MD, FMedSci, and Georg Stingl, MD, as they share perspectives shaping the next generation of psoriasis research.
The IPC Resource Library now includes a dedicated Research Skills category, bringing together videos, articles, and presentations focused on building stronger research capabilities in psoriasis. Browse the current collection to find resources on topics from collaborative research methods to career development for researchers at every stage.
Rare ADAR1 gene mutations drive a distinct, interferon-fueled psoriasis subtype, and it responds to JAK1 and TYK2 inhibitors rather than standard IL-17/IL-23 biologics.
IPC Councilor Anna Lopez Ferrer, MD, PhD, reviews PURE-4, a four-item tool that helps dermatologists screen psoriasis patients for psoriatic arthritis (PsA) risk. She traces its evolution across three studies (2018–2026) into a validated predictor of early PsA.
IPC Councilor André Lucas Ribeiro, MD, reframes PsA as a slow transition from psoriasis, not a sudden event, opening the door to disease interception. He outlines the steps needed to get there, from harmonizing definitions to reducing inflammatory burden.
